Pfizer swings to quarterly loss due to Paxlovid write-off
Published
Pfizer PFE-N on Tuesday reported its first quarterly loss since 2019, as the U.S. drugmaker recorded $5.6 billion in charges related to its COVID products like its antiviral treatment Paxlovid and vaccine Comirnaty. The company posted a loss of 42 cents per share for the third quarter. It had…
#pfizerpfen #comirnaty #pfizer